Skip to main content

Table 1 Clinico-pathological characteristics of prostate samples

From: Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer

    WHOLE TISSUE MICRODISSECTED (μD)
CASEa GLEASON SCORE STAGE TUMORAL SAMPLES %EPb %Tc NORMAL SAMPLES %EPb %Tc STROMAL SAMPLES NORMAL SAMPLES TUMORAL SAMPLES
1 6 (3+3) T2 T1d, e 70 40 N1d, e 40 0 - N1-μDe T1-μDe
2 9 (4+5) T3a T2d 90 100 N2d 50 0 - - -
3 5 (2+3) T3a T3d, e 80 85 N3d, e 40 0 - N3-μDe T3-μDe
4 7 (3+4) T2 T4d 60 80 N4d 40 0 - N4-μDe T4-μDe
5 7 (4+3) T2 T5d 65 90 N5d 45 0 - - -
6 9 (5+4) T2 T6d, e 80 100 N6d, e 40 0 - N6-μDe T6-μDe
7 7 (3+4) T3a T7d, e 80 100 N7d, e 55 0 - N7-μDe T7-μDe
8 7 (3+4) T2c T8d 80 100 - - - S1 - -
9 8 (3+5) T2 T9d 80 90 - - - - - -
10 7 (3+4) T3a T10d 80 100 - - - - - -
11 7 (3+4) T3a T11d 70 80 - - - - - -
12 7 (3+4) T3a T12d 50 90 - - - - - -
13 9 (4+5) T3a T13d 80 100 - - - - - -
14 7 (3+4) T3a T14d 65 90 - - - - N14-μDe T14-μDe
15 7 (3+4) T3a T15d 70 100 - - - - - -
16 5 (2+3) T2 T16d 80 90 - - - - N16-μDe T16-μDe
17 7 (3+4) T3a T17d 80 95 - - - - - -
18 8 (3+5) T2 T18d 65 95 - - - - - -
19 6 (3+3) T2 T19d 70 90 - - - - - -
20 7 (4+3) T3a T20d 60 80 - - - - - -
21 - - - - - - - - S2 - -
22 - - - - - - - - S3 - -
  - - - - - POOL Nd 45 0 - - -
  1. aSamples in the same case line were obtained from the same patient.
  2. bPercentage of epithelial cells.
  3. cPercentage of epithelial cells with morphological features of carcinoma.
  4. dSamples used in microarray analysis.
  5. eSamples used in Q-PCR analysis